SXTC · China SXT Pharmaceuticals, Inc.
$0.08
+0.03 (+53.71%)
At close · Jul 30
Market Cap
$2.01M
Shares
38.22M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$1.14M
-34.6%
FY2026
Net Income
-$6.21M
-87.8%
FY2026
Gross Margin
21.85%
+0.7pp
FY2026
Operating Margin
-625.89%
-471.9pp
FY2026
Diluted EPS
-$9.13
+97.4%
FY2026
Operating Cash Flow
-$4.02M
-71.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| $1.14M | $1.74M | $1.93M | $1.97M | $2.6M | $4.78M | $5.16M | $7.01M | $7.02M | $4.88M | |
| $889.35K | $1.37M | $1.37M | $1.55M | $1.35M | $1.94M | $2.46M | $2.4M | $3.62M | $2.57M | |
| $248.7K | $367.43K | $553.97K | $426.27K | $1.25M | $2.84M | $2.7M | $4.61M | $3.4M | $2.31M | |
| 21.85% | 21.11% | 28.73% | 21.62% | 48.1% | 59.43% | 52.37% | 65.77% | 48.46% | 47.36% | |
| — | — | $184.19K | $200.72K | $367.01K | — | — | — | — | — | |
| $244.19K | $289.86K | $433.57K | $387.45K | $924.54K | $1.59M | — | — | — | — | |
| $7.13M | $2.76M | $2.64M | $5.65M | $5.52M | $3.45M | $2.46M | $1.24M | $1.26M | $565.46K | |
| $5825 | $7238 | $7459 | $7932 | $8468 | $8012 | $7985 | $6967 | $6169 | $4819 | |
| $73.67K | $82.3K | $203.25K | $250.16K | $320.01K | $345.41K | $331.84K | $180.92K | $129.44K | — | |
| — | — | $422.92K | $349.39K | — | — | — | — | — | — | |
| $7.37M | $3.05M | $3.07M | $6.03M | $6.44M | $5.04M | $4.04M | $2.84M | $1.77M | $709.82K | |
| -$7.12M | -$2.68M | -$2.52M | -$5.61M | -$5.19M | -$2.2M | -$1.34M | $1.77M | $1.63M | $1.6M | |
| -625.89% | -153.97% | -130.42% | -284.4% | -199.43% | -45.99% | -25.98% | 25.24% | 23.25% | 32.82% | |
| -$7.05M | -$2.6M | -$2.31M | -$5.36M | -$4.87M | -$1.85M | -$1.01M | $1.95M | $1.76M | — | |
| $62.97K | $648.22K | $544.28K | $476.78K | $36.7K | $1.62M | $3.35M | $5174 | $779 | $40.39K | |
| $917.85K | -$623.17K | -$583.32K | -$327.26K | -$218.28K | -$743.79K | -$9.05M | $21.97K | -$4582 | -$21.99K | |
| -$6.21M | -$3.3M | -$3.1M | -$5.93M | -$5.41M | -$2.94M | -$10.39M | $1.79M | $1.63M | $1.58M | |
| — | — | — | — | $328.15K | -$192.68K | -$101.72K | $252.23K | $440.1K | $395.05K | |
| -$6.21M | -$3.3M | -$3.1M | -$5.93M | -$5.74M | -$2.75M | -$10.29M | $1.54M | $1.19M | $1.19M | |
| -545.24% | -189.77% | -160.67% | -301% | -220.43% | -57.52% | -199.29% | 21.95% | 16.92% | 24.28% | |
| -$5.33M | -$3.35M | -$3.93M | -$7.09M | -$5.31M | -$1.63M | -$10.93M | $1.33M | $1.43M | $1.11M | |
| USD/shares | -$9.13 | -$348.17 | -$4,285.66 | -$26,675.55 | -$20,687.70 | -$14,321.25 | $124,807.50 | $1,125.00 | $885.00 | $885.00 |
| USD/shares | -$9.13 | -$348.17 | -$4,285.66 | -$26,675.55 | -$20,687.70 | -$14,321.25 | — | $1,125.00 | $885.00 | $885.00 |
| shares | 679.65K | 9489 | 723 | 222.48 | 277.2733 | 191.8797 | 82.4288 | 1371.242 | 1333.3333 | 1333.3333 |
| shares | 679.65K | 9489 | 723 | 222.48 | 277.2733 | 191.8797 | 1648.5771 | 1371.242 | 1333.3333 | 1333.3333 |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Revenues from Third Parties | $1,138,011 | $1,736,606 | $1,900,737 | $1,938,058 | $2,263,155 |
| Regular TCMP | $1,081,400 | $1,442,466 | — | — | — |
| Advanced TCMP | $49,516 | $258,416 | — | — | — |
| Others | $7,136 | $40,025 | — | — | — |
| Revenue from Related Parties | $41 | $4,301 | $27,760 | $33,621 | $339,126 |
Key facts
CIK
1723980
CUSIP
G2161P165